戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 oride, sodium), creatinine, urea, and random blood sugar).
2 ate, with higher-GI foods rapidly increasing blood sugar.
3 ed obesity, cholesterol, blood pressure, and blood sugar.
4  variable, accuracy at times of low and high blood sugar.
5 ad (GL), which identify foods that stabilize blood sugar.
6                  They too had normal fasting blood sugars.
7  improve outcomes more than tight control of blood sugars.
8 were treated with insulin to normalize their blood sugars.
9 /L; 95% CI: -0.03, 0.28 mmol/L), and fasting blood sugar (-0.16 mmol/L; 95% CI: -0.44, 0.11 mmol/L).
10                                      Fasting blood sugar, 2-h post prandial glucose, or using anti-di
11 ing glucose levels by decreasing the rate of blood sugar absorption.
12 ing glucose levels by decreasing the rate of blood sugar absorption.
13  The pattern of diabetic care and control of blood sugar among diabetic patients are not well describ
14 eakfast skipping) on lipid profiles, fasting blood sugar and body composition in Ethiopian set up.
15 le health effects on lipid profiles, fasting blood sugar and body composition.
16  in addressing the increasing burden of high blood sugar and inform the potential impact of different
17 istration of anti-resistin antibody improves blood sugar and insulin action in mice with diet-induced
18 l obesity, high blood pressure, and abnormal blood sugar and lipid levels, is a growing global health
19 e were treated with the RIPtk gene, and both blood sugars and animal viability were monitored.
20 ed atherosclerotic process, managing lipids, blood sugar, and blood pressure.
21 ), respectively; obesity, hypertension, high blood sugar, and regular cigarette smoking were rare.
22 ith the risk of high blood pressure, fasting blood sugar, and triglycerides, with marginal significan
23                                 Age, fasting blood sugar, and years of diabetes mellitus were correla
24 on-beta-cells that are capable of modulating blood sugar; and the construction of synthetic 'cells' o
25 t how the counterregulatory responses to low blood sugar are affected under these metabolic condition
26 e present study was to determine whether low blood sugar augments glucagon's ability to increase gluc
27                        While improvements in blood sugar, blood pressure, and attenuation of kidney d
28                  Blood pressure, non-fasting blood sugar, body mass index and abdominal girth were me
29 in supplementation also led to lower fasting blood sugar, body mass index, and total cholesterol.
30 r type 2 diabetes, metformin, not only lower blood sugar, but also promote longevity in preclinical m
31  when diabetic patients try to control their blood sugar, but the molecular mechanism of this 'metabo
32                                     Lowering blood sugar by the sodium-glucose co-transporter 2 inhib
33 ese findings support the hypothesis that low blood sugar causes greater participant cooperation - whi
34 vascular biomarkers, including lipoproteins, blood sugar, circulatory pressure, proinflammatory marke
35 erapies to control cerebral amyloid-beta and blood sugar concentrations.
36 e for individuals with diabetes by improving blood sugar control and limiting the risk of hypoglycemi
37 cose and lipid metabolism, leading to better blood-sugar control and decreased insulin resistance.
38  describes how a food, meal, or diet affects blood sugar during the postprandial period.
39 his hormone peptide in a hyperglycemia (high blood sugar) environment.
40                                      Fasting blood sugar (FBS = 189.08 +/- 51.3 mg/dl) and diabetes m
41 ted with an increased risk of higher fasting blood sugar (FBS) (OR = 6.07; 95% CI: 1.33-27.74, P valu
42 ver craniocaudal length (P = 0.012), fasting blood sugar (FBS) (P = 0.047), aspartate aminotransferas
43 garding diabetes-related traits like fasting blood sugar (FBS) and type 2 diabetes (T2D) and glaucoma
44 oglobin (HbA1c), and mean changes in fasting blood sugar (FBS) level, body weight (BW) and homeostasi
45 body mass index (BMI) (p < 0.05) and fasting blood sugar (FBS) levels (p < 0.05).
46 albumin, complete blood count (CBC), fasting blood sugar (FBS), Alanine aminotransferase (ALT), and a
47 e-responsive) improve outcomes by minimising blood sugar fluctuations.
48 andial glycemic response, or the increase in blood sugar following a meal, is a crucial component to
49  strain should provide utility in separating blood sugar from blood pressure-related treatment effect
50  drink causes some participants who have low blood sugar from fasting to give lower slant estimates.
51 that can reveal a patient's average level of blood sugar from the past 2-3 months instead of just mea
52 tion (ureagenesis) and regulation of fasting blood sugar (gluconeogenesis).
53 DAN score (0 to 6 points) comprises baseline blood Sugar (glucose; 8.1-12.0 mmol/l [145-216 mg/dl] =
54                                     Weights, blood sugar, glycosylated hemoglobin, and detailed ERGs
55                    At the time of rejection (blood sugar &gt;300 mg/100 ml), grafts were harvested and a
56                        Haematological tests (blood sugar, HbA1c and lipid profile, 31.8%), OCT (27.4%
57 d metabolic dysregulation (obesity, elevated blood sugar, high blood pressure, high levels of triglyc
58 Buruli ulcer pathogenesis is that changes in blood sugar homeostasis in infected patients are mirrore
59 ptor (GCGR), a Family B GPCR responsible for blood sugar homeostasis, and broadly inhibits receptor-i
60 h as lipid levels, circulating sex hormones, blood sugar homeostasis, inflammation and immune functio
61 reas has the crucial function of maintaining blood sugar homeostasis.
62 m pancreatic beta cells, which is central to blood-sugar homeostasis.
63 ent disease, primarily characterized by high blood sugar (hyperglycemia).
64 ent on the counterregulatory response to low blood sugar in dogs.
65                           In this study, the blood sugar in methadone poisoning cases was statistical
66 ation significantly reduced the elevation in blood sugar in mice following an oral but not intraperit
67 s a crucial component to maintaining healthy blood sugar in patients with diabetes.
68          HOMA-beta, HOMA-IR, QUICKI, fasting blood sugar, insulin, and SPX were measured in liver and
69                                To avoid high blood sugar, it is important for people to be able to pr
70  days exhibited similar or better control of blood sugar level (20% reduction in HbA1c) and weight co
71 ound that when APR systemically quenched the blood sugar level in diet-induced obesity (DIO) diabetic
72 articles had no effect on the body weight or blood sugar level of rats.
73 n premedication, Wistar male rats presenting blood sugar levels >20 mmol/L were selected for investig
74 serum antibody titers to these bacteria, and blood sugar levels (glycosylated hemoglobin, HbAlc) were
75 significant changes in creatinine, urate, or blood sugar levels after conversion, but the mean plasma
76 bin A1c (HbA1c) provides an estimate of mean blood sugar levels and glycemic control.
77 ame protocol was used on animals with normal blood sugar levels and healthy gingiva.
78                                              Blood sugar levels and insulin sensitivity was not affec
79                       They can also regulate blood sugar levels and lower cholesterol to reduce the e
80                        Empagliflozin lowered blood sugar levels compared to vehicle treated animals (
81  physiological adaptation to maintain normal blood sugar levels during sleep loss.
82 del with increased blood pressure und higher blood sugar levels had a reduced survival compared to co
83                  The accurate measurement of blood sugar levels in a single drop of whole blood with
84                                          The blood sugar levels of GK rats are significantly higher t
85 to insulin or fail to produce it adequately, blood sugar levels rise.
86                  Graft survival monitored by blood sugar levels was compared among the groups.
87 d 5 days after the start of treatment, lower blood sugar levels were observed in the particle treatme
88                      Given that diet affects blood sugar levels, and carnivores have higher cancer ri
89   People with diabetes need to control their blood sugar levels.
90 the brain's ability to sense dangerously low blood sugar levels.
91 abolism may identify new strategies to lower blood sugar levels.
92 sulin secretion and effectively lowers their blood sugar levels.
93 blood pressure, low blood pressure, and high blood sugar levels.
94          One MN patch can quickly reduce the blood-sugar levels (BGLs) of chemically induced type-1 d
95  Biochemical parameters such as FBS (fasting blood sugar), lipid profile, and liver and kidney functi
96 ted of poisoning with illicit drugs and high blood sugar, methadone poisoning should be considered in
97  A significant decrease in BMI (Kg/m(2)) and blood sugar (mg/dL) levels, while an increase in systoli
98                              Controlling the blood sugar of diabetic mice with insulin resulted in si
99 ical setting improves outcomes compared with blood sugars of approximately 150 mg/dl.
100                                         High blood sugar over long term leads to many other health co
101 cept for people with diabetes and those with blood sugar problems), desirable flavor, and taste,maple
102 , periodontal index, body mass index, random blood sugar (RBS), and glycated hemoglobin (HbA1c).
103 ally reduce the GI, contributing to improved blood sugar regulation and overall metabolic health.
104                                      Fasting blood sugar, serum insulin, fasting serum lipids and ser
105 o produce insulin Abs that may lower fasting blood sugars similar to an insulin autoimmune syndrome.
106 le to be able to predict what will happen to blood sugar so that they can do something to prevent hyp
107                    CH(4) breath tests (MBT), blood sugar tests (BST) and clinical symptoms were compa
108 els (cholesterol and triglycerides) and high blood sugar that can lead to HTN and DM.
109 n B to 2p24-25; weight to 18q21; and fasting blood sugar to 1q31-1q43.
110 andomized clinical trials to gradually lower blood sugar to near normal levels.
111 gher body mass index, transaminases, fasting blood sugar, triglyceride, low density lipoprotein level
112       Shortly after admission, the patient's blood sugar was controlled with insulin; this led to a s
113                           Similarly, fasting blood sugar was high among non-fasters (100.14 mg/dl) co
114                                              Blood sugars, weights, and ERGs were measured for a grou
115                              Improvements in blood sugar were due in part to increased glucose uptake
116                              Body weight and blood sugar were monitored.
117 ressure, low-density lipoprotein, and random blood sugar were significantly higher in NP+C and P+C, w
118 ious history of diabetes or elevated fasting blood sugar were studied.
119 uous measures for blood pressure and fasting blood sugar were used instead of hypertension and diabet
120 ns were markedly elevated, but their fasting blood sugars were normal.
121 d consistently more often when their owner's blood sugars were reported to be outside, than within, t
122 he enhanced hyperammonemia and lower fasting blood sugar, which are both seen in the DKO mice, indica
123                               The control of blood sugar (with similar doses of insulin) achieved by

 
Page Top